Zieroth S - Search Results

1

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.

Raj P, Thandapilly SJ, Wigle J, Zieroth S, Netticadan T. Raj P, et al. Among authors: zieroth s. Molecules. 2021 Oct 31;26(21):6600. doi: 10.3390/molecules26216600. Molecules. 2021. PMID: 34771008 Free PMC article. Review.

2

Factors Impacting Physician Prognostic Accuracy in Heart Failure Patients With Reduced Left Ventricular Ejection Fraction.

Alba AC, Buchan TA, Saha S, Fan S, Poon S, Mak S, Al-Hesayen A, Toma M, Zieroth S, Anderson K, Demers C, Amin F, Porepa L, Chih S, Giannetti N, Rac V, Ross HJ, Guyatt GH. Alba AC, et al. Among authors: zieroth s. JACC Heart Fail. 2024 May;12(5):878-889. doi: 10.1016/j.jchf.2024.02.009. Epub 2024 Mar 27. JACC Heart Fail. 2024. PMID: 38551522 Free article.

3

Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes.

Kanumilli N, Butler J, Makrilakis K, Rydén L, Vallis M, Wanner C, Zieroth S, Alhussein A, Cheng A. Kanumilli N, et al. Among authors: zieroth s. Diabetes Ther. 2023 Jul;14(7):1093-1110. doi: 10.1007/s13300-023-01418-0. Epub 2023 May 18. Diabetes Ther. 2023. PMID: 37199909 Free PMC article. Review.

4

Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Dhalla NS, Rangi S, Babick AP, Zieroth S, Elimban V. Dhalla NS, et al. Among authors: zieroth s. Heart Fail Rev. 2012 Sep;17(4-5):671-81. doi: 10.1007/s10741-011-9278-7. Heart Fail Rev. 2012. PMID: 21850540 Review.

5

Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction.

Babick A, Chapman D, Zieroth S, Elimban V, Dhalla NS. Babick A, et al. Among authors: zieroth s. J Cell Mol Med. 2012 Dec;16(12):2958-67. doi: 10.1111/j.1582-4934.2012.01623.x. J Cell Mol Med. 2012. PMID: 22947202 Free PMC article.

6

Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction.

Babick A, Elimban V, Zieroth S, Dhalla NS. Babick A, et al. Among authors: zieroth s. J Cell Physiol. 2013 Oct;228(10):2063-70. doi: 10.1002/jcp.24373. J Cell Physiol. 2013. PMID: 23553674

7

Potential of resveratrol in the treatment of heart failure.

Raj P, Louis XL, Thandapilly SJ, Movahed A, Zieroth S, Netticadan T. Raj P, et al. Among authors: zieroth s. Life Sci. 2014 Jan 30;95(2):63-71. doi: 10.1016/j.lfs.2013.12.011. Epub 2013 Dec 20. Life Sci. 2014. PMID: 24361400 Review.

8

An overview of the efficacy of resveratrol in the management of ischemic heart disease.

Raj P, Zieroth S, Netticadan T. Raj P, et al. Among authors: zieroth s. Ann N Y Acad Sci. 2015 Aug;1348(1):55-67. doi: 10.1111/nyas.12828. Epub 2015 Jul 30. Ann N Y Acad Sci. 2015. PMID: 26227659 Review.

9

Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.

Raj P, Aloud BM, Louis XL, Yu L, Zieroth S, Netticadan T. Raj P, et al. Among authors: zieroth s. J Nutr Biochem. 2016 Feb;28:155-63. doi: 10.1016/j.jnutbio.2015.09.025. Epub 2015 Oct 19. J Nutr Biochem. 2016. PMID: 26878793

10

Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent? ¹.

Louis XL, Raj P, Chan L, Zieroth S, Netticadan T, Wigle JT. Louis XL, et al. Among authors: zieroth s. Can J Physiol Pharmacol. 2019 Jun;97(6):503-514. doi: 10.1139/cjpp-2018-0544. Epub 2018 Dec 21. Can J Physiol Pharmacol. 2019. PMID: 30576226 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters